Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression

Autoimmunity
Yuquan BaiJinping Zhao

Abstract

Oestrogen receptor beta (ERβ) and epidermal growth factor receptor (EGFR) pathway can synergistically promote the proliferation, invasion, and metastasis of non-small-cell lung cancer (NSCLC) cells. ERβ has five subtypes, and the selective splicing of exon 8 in ERβ5 transcription translational phase makes its biological function different from other subtypes. The following study investigates whether ERβ5 interacts with EGFR pathway in lung cancer. Briefly, we found that the overexpression of ERβ5 and EGFR is associated with poor prognosis and decreased overall survival in NSCLC patients. Furthermore, the effects of ERβ5 and EGFR on cell biological behaviour were investigated in vitro. These results indicated that the combination of ERβ5 and EGF induces cell proliferation and invasion, while the combination of ERβ5 and Gefitinib (EGFR inhibitors, Gef) induces cell apoptosis and promotes cell mitosis in A549 cell line. In addition, the combination of ERβ5 and EGF increases the expression of ERβ5, EGFR, and p-ERK1/2 in lung cancer cells. To sum up, the obtained results suggest that ERβ5 and EGFR synergistically promote the progression of lung cancer by activating MEK/ERK signalling pathway, which provides a theoretical basis for m...Continue Reading

References

Jun 24, 1998·Biochemical and Biophysical Research Communications·J T MooreT M Willson
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G SelvaggiG V Scagliotti
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yuet-Kin LeungShuk-Mei Ho
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maurizio Scaltriti, José Baselga
Feb 26, 2009·Journal of Carcinogenesis·Neelu Puri, Ravi Salgia
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 17, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hua ShenYong-Qian Shu
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
May 8, 2013·International Journal of Cancer. Journal International Du Cancer·Hexiao TangSheng Zhou
May 16, 2013·American Journal of Respiratory Cell and Molecular Biology·Alexander V MisharinHarris Perlman
Jan 18, 2014·The European Respiratory Journal·Sabari VallathAdam Giangreco
Oct 24, 2014·Cancer Science·Li-Han HsuShu-Huei Kao
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 22, 2015·Asian Pacific Journal of Tropical Medicine·Chong ShiShu-Wang Yin
Dec 17, 2015·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yan-Hong WeiSheng Zhou
Apr 14, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mary O HuffCarolyn M Klinge
Jun 12, 2017·Biochemistry. Biokhimii︠a︡·A M SurinV G Pinelis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sae-Won HanNoe Kyeong Kim
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jenn-Yu WuPan-Chyr Yang
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Fei MaDongxin Lin
© 2022 Meta ULC. All rights reserved